IRIX 8-K
Iridex Corp (IRIX)
UNITED STATES Washington, D.C. 20549 |
||||
|
||||
FORM CURRENT REPORT |
||||
|
||||
PURSUANT TO SECTION 13 OR 15(d) OF THE |
||||
|
|
|||
(Date of Report (date of earliest event reported)) |
||||
|
||||
(Exact name of registrant as specified in its charter) |
||||
|
||||
(State or other jurisdiction of |
(Commission File Number) |
(I.R.S. Employer |
||
(Address of principal executive offices, including zip code) |
||||
|
||||
( |
||||
(Registrant’s telephone number, including area code) |
||||
(Former name or former address, if changed since last report) |
||||
|
||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
||||
|
||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
||||
Emerging growth company |
||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
||||
Securities registered pursuant to Section 12(b) of the Act:
Title of Class |
|
Trading Symbol |
|
Name of Exchange on Which Registered |
|
|
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Committee Assignments
On June 18, 2024, the board of directors of IRIDEX Corporation (the “Company”) modified the composition of its Audit Committee to consist of the following directors:
Item 5.07. Submission of Matters to a Vote of Security Holders.
The 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of the Company was held on June 18, 2024, at the Company’s headquarters located at 1212 Terra Bella Avenue, Mountain View, CA 94043. As of April 25, 2024, the record date of the Annual Meeting, 16,252,948 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. Present at the Annual Meeting in person or by proxy were holders of 10,605,381 shares, or 65.25%, of the Company’s common stock, constituting a quorum for the transaction of business. The proposals voted upon at the meeting and the vote with respect to each such matter are as set forth below:
Proposal 1: Election of Directors.
Nominee |
For |
Withheld |
Broker Non-Votes |
David I. Bruce |
5,036,255 |
1,296,459 |
4,272,667 |
Robert Grove, Ph.D. |
5,063,161 |
1,269,553 |
4,272,667 |
Beverly A. Huss |
5,597,417 |
735,297 |
4,272,667 |
Kenneth E. Ludlum |
5,050,257 |
1,282,457 |
4,272,667 |
Scott Shuda |
5,680,036 |
652,678 |
4,272,667 |
Based on the votes set forth above, each director nominee was duly elected to serve until the 2025 Annual Meeting of Stockholders or until his or her respective successor is duly elected and qualified or until his or her earlier death, resignation or removal.
Proposal 2: To ratify the appointment of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 28, 2024.
For |
Against |
Abstain |
Broker Non-Votes |
10,213,704 |
94,347 |
297,330 |
0 |
Based on the votes set forth above, the stockholders ratified the appointment of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 28, 2024.
Proposal 3: To conduct an advisory vote to approve the compensation of the Company’s named executive officers.
For |
Against |
Abstain |
Broker Non-Votes |
4,635,945 |
1,352,835 |
343,934 |
4,272,667 |
The stockholders approved the compensation of the Company’s named executive officers on an advisory vote.
Item 9.01. Financial Statements and Exhibits.
-2-
(d) |
Exhibits |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
-3-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
IRIDEX CORPORATION |
|
|
|
|
|
By: |
|
/s/ David I. Bruce |
|
|
|
David I. Bruce |
|
|
|
Chief Executive Officer |
|
|
|
|
Date: June 20, 2024 |
|
|
|
-4-